SCHEMBL6569743

SCHEMBL6569743

CCCCCCCCCCCCCC/C=C/C[C]=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.58
TRPV1 Q8NER1 1/20 0.58
TERT O14746 3/20 0.50
PTPN1 P18031 3/20 0.50
PPARG P37231 3/20 0.50
PPARD Q03181 3/20 0.50
PPARA Q07869 3/20 0.50
TOP1 P11387 3/20 0.50
CYP1A2 P05177 2/20 0.50
MAPT P10636 2/20 0.50
CYP2C19 P33261 2/20 0.50
BLM P54132 2/20 0.50
HSD17B10 Q99714 2/20 0.50
FABP4 P15090 2/20 0.50
KMT2A Q03164 2/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
POLB P06746 1/20 0.50
CYP2C9 P11712 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7288642 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL7357636 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL4963683 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL9949863 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL7288637 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL7357239 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL6625727 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL7358985 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL21777211 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL7358983 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105051051-B Method for synthesizing sphingomyelin and dihydrosphingomyelin 萨瑞斯治疗控股公司 2021-07-16 CN disclosed
CN-105051051-A Methods for the synthesis of sphingomyelins and dihydrosphingomyelins CERENIS THERAPEUTICS HOLDING S A 2015-11-11 CN disclosed
EP-1385478-A2 METHOD FOR APPLYING AN ACTIVE INGREDIENT TO A SUBSTRATE, COMPOSITIONS FOR SAID METHOD, CONTAINER CONTAINING A COMPOSITION AND USE OF SAID COMPOSITIONS VESIFACT AG (CH) 2004-02-04 EP disclosed
WO-2002089769-A2 METHOD FOR APPLYING AN ACTIVE INGREDIENT TO A SUBSTRATE, COMPOSITIONS FOR SAID METHOD, CONTAINER CONTAINING A COMPOSITION AND USE OF SAID COMPOSITIONS VESIFACT AG (CH) 2002-11-14 WO disclosed